Global Kidney Transplant Market - 2025 - 2033

Global Kidney Transplant Market - 2025 - 2033

The global kidney transplant market reached US$ 7.65 billion in 2023 and is expected to reach US$ 11.10 billion by 2033, growing at a CAGR of 3.7% during the forecast period 2025-2033.

A kidney transplant is a surgical procedure to transplant a healthy kidney from a living or deceased donor into a person whose kidneys are no longer functioning properly. The kidneys, two bean-shaped organs located on each side of the spine, filter and remove waste, minerals, and fluid from the blood by producing urine. When kidneys lose their filtering ability, harmful fluid and waste accumulate, leading to kidney failure (end-stage renal disease). This occurs when the kidneys lose about 90% of their normal function.

Market Dynamics: Drivers & Restraints

Rise in the Prevalence of Kidney Diseases

The global kidney transplant market is fueled by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), largely due to factors like aging populations, lifestyle disorders, and obesity. These conditions often result in irreversible kidney damage, necessitating renal replacement therapies like dialysis or transplantation. The demand for kidney transplants is growing due to their higher quality of life and better long-term outcomes. Advancements in surgical techniques, improved immunosuppressive drugs, and increased organ donation awareness further support this trend.

For instance, according to the United States Renal Data System 2023 Annual Data Report shows that over 808,000 people in the US are living with end-stage renal disease (ESRD), with 68% on dialysis and 32% with a kidney transplant. Males are 1.6 times more likely to develop ESKD than females. Black people are more than 4 times more likely to develop ESKD than White people, while Hispanic and Native American people are more than twice as likely. Asian people are 1.6 times more likely to develop ESKD. Black people account for 30% of the total number of ESKD cases, with the number of Hispanic, Native Hawaiian, Other Pacific Islander, and Asian people with kidney failure more than tripled since 2001.

High Cost Associated with Transplantation

The high cost of kidney transplantation poses a significant challenge to the global market, restricting access for many patients. The procedure involves significant expenses, including pre-operative evaluations, surgical fees, hospitalization, and post-transplant care. These costs are often not fully covered by insurance or government healthcare programs, particularly in low- and middle-income countries with limited healthcare infrastructure. This financial barrier also contributes to disparities in transplantation access, forcing many patients to rely on less effective treatments like dialysis.

For instance, the average kidney transplant cost was $442,500, with admission charges accounting for 34% of the total cost. Despite rising medication prices, only 7% of the total costs are for immunosuppression and transplant-related medications like prophylactic antibiotics, despite the rising costs of medications.

Segment Analysis

The global kidney transplant market is segmented based on transplant type, technology, age group, end user and region.

Transplant Type:

Living Donor Transplant segment is expected to dominate the Kidney Transplant market share

The living donor transplant segment holds a major portion of the kidney transplant market share and is expected to continue to hold a significant portion of the kidney transplant market share during the forecast period.

Living donor transplantation is a crucial solution to the global kidney transplant market, addressing the shortage of deceased organs. It allows patients to receive kidneys from healthy, willing donors, often family members or close acquaintances, reducing waiting times and improving patient outcomes. Living donor transplants have higher success rates due to controlled conditions and advanced surgical techniques like laparoscopic nephrectomy. However, ethical considerations, donor health risks, and compatibility testing remain challenges. Despite these, living donor transplants are actively promoted through awareness campaigns and support programs.

For instance, in April 2023, The American Liver Foundation (ALF) and the American Society of Transplantation (AST) have formed a strategic partnership within the Living Donor Circle of Excellence. ALF will become the first liver organization to join AST's Living Donor Circle of Excellence, which celebrates employers providing salary support to employees who become living organ donors. The partnership aims to break down barriers to living donor liver transplants and ensure job security and paid leave for employees.

End User:-

Hospitals segment is the fastest-growing segment in Kidney Transplant market share

The hospitals segment is the fastest-growing segment in the kidney transplant market share and is expected to hold the market share over the forecast period.

Hospitals are vital in the global kidney transplant market, providing comprehensive pre- and post-operative care, patient evaluation, organ matching, and surgical interventions. They manage complex care protocols, including immunosuppressive therapy, infection control, and long-term monitoring of transplant recipients. Many hospitals collaborate with organ procurement organizations to facilitate organ allocation and donor matching. The availability of advanced medical infrastructure and skilled healthcare professionals directly impacts the success rates of kidney transplants. However, the disparity in quality and accessibility of transplant services between developed and developing regions highlights the need for investments in healthcare infrastructure and training.

For instance, in August 2024, Hospital Clínic Barcelona has performed its sixth kidney transplant in Spain, marking the first time such a procedure has been performed in the country. The transplant was carried out by the Hospital Clínic Nephrology and Urology Institute, led by Dr. Rosa Ramos, with the Urology Service team led by Dr. Antonio Alcaraz.

Geographical Analysis

North America is expected to hold a significant position in the Kidney Transplant market share

North America holds a substantial position in the kidney transplant market and is expected to hold most of the market share due to strong transplant infrastructure, and well-established organ donation frameworks. The country's specialized transplant centers, advanced surgical techniques, and availability of immunosuppressive drugs contribute to high success rates. The National Organ Transplant Act promotes organ donation and supports transplant programs. The high prevalence of chronic kidney disease and end-stage renal disease, driven by lifestyle factors, further increases demand for kidney transplants. Increased public awareness and government funding further stimulate market growth.

For instance, in December 2024, A new final rule issued by the Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services this week for a mandatory alternative payment model called the Increasing Organ Transplant Access (IOTA) Model aimed to improve the number of life-saving kidney transplants for patients whose kidneys have failed. The new rule will test whether performance-based upside or downside risk payments among a selected subset of kidney transplant hospitals increase access to kidney transplants for patients with end-stage kidney disease while maintaining or improving the quality of care and reducing Medicare costs.

Europe is growing at the fastest pace in the Kidney Transplant market

Europe holds the fastest pace in the kidney transplant market and is expected to hold most of the market share due to a robust healthcare infrastructure and efficient organ donation systems. Countries like Germany, the UK, and France have advanced transplant programs and established transplant centers. Eurotransplant, a unified system, improves transplant access and success rates. Government-backed policies and public awareness campaigns also contribute to donor registrations. Europe faces high chronic kidney disease incidence due to aging populations and lifestyle-related conditions. Advances in medical technology, such as minimally invasive surgical procedures, further fuel the market's growth.

For instance, according to Kidney Research UK, around 5,000 UK patients are waiting for kidney transplants, but only 3,600 are carried out annually. The average wait for a deceased donor kidney transplant is 2-3 years. Patients with complete kidney failure require lifelong dialysis treatment or a transplant. However, transplants last 10-15 years and may require further transplants or dialysis if they fail. Kidney Research UK is dedicated to funding research to improve transplant longevity and effectiveness, and increasing organ availability for transplants.

Competitive Landscape

The major global players in the kidney transplant market include Transonic, Sanofi S.A., Organ Recovery Systems, Inc, Pfizer Inc, TransMedics Inc, Novartis AG, Preservation Solutions Inc., B. Braun Melsungen AG, Medtronic plc, Fresenius Medical Care AG & Co. and among others.

Key Developments
• In May 2024, Thermo Fisher Scientific has launched the CXCL10 testing service, aimed at improving post-transplant care for kidney transplant patients. The noninvasive test uses urine samples and can produce results within 24 hours. It can detect the CXCL10 chemokine, potentially providing faster information than current tests. Elevated urinary CXCL10 levels are linked to inflammation and early kidney transplant rejection.
• In May 2024, The U.S. Department of Health and Human Services (HHS) is launched the Increasing Organ Transplant Access (IOTA) Model to improve kidney transplant access, quality of care, and reduce disparities. The model targets transplant hospitals, requiring a minimum of 11 transplants annually over three years. Participating hospitals must develop health equity plans.

Why Purchase the Report?
• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global kidney transplant market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023
• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Age Group & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.